Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its ...

By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s ...

One of the worst complications of adult-onset Still's disease is macrophage activation syndrome (MAS), which can be fatal. In ...

Affiliate content. Discover the best products for arthritis in hands, including supplements, creams, and tools designed to reduce pain, inflammation, and improve mobility.

Vamorolone showed promising results to effectively treat inflammation whilst minimising negative side compared to current ...

Irish research has found that the illness affects one in 50 children and early diagnosis and treatment is crucial ...

I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.

Patients are taking part in a trial that scientists hope could ultimately lead to a cure for rheumatoid arthritis. The ...

Upadacitinib sustains its efficacy in non-radiographic axial spondyloarthritis through 2 years without presenting any new ...